Article de revue

Achieving high uptake of human papillomavirus vaccine in Cameroon: Lessons learned in overcoming challenges

With adequate education of all stakeholders, HPV vaccination is acceptable and feasible in Cameroon. Following this demonstration project, in 2014 the Global Access to Vaccines and Immunization (GAVI) Alliance awarded the Cameroon MOH HPV vaccine at a price of US$4.50 per dose to immunize sixth grade girls and girls aged 10 years who are not in school in two districts of Cameroon.

Langues

  • Anglais

Année de publication

2014

Journal

Vaccine

Volume

35

Type

Article de revue

Catégories

  • Prestation de services

Maladies

  • Papillomavirus humain

Pays

  • Cameroun

Organisations

  • Gavi, l'Alliance du vaccin

Mots-clés

  • Introduction de nouveaux vaccins
  • Suivi de performance
  • Planification, budgétisation et financement

Régions de l'OMS

  • Région africaine

Ajouté par: Moderator

Ajouté le: 2015-11-21 06:21:30

Consultations: 983